206 related articles for article (PubMed ID: 36779885)
1. Metabolic Consequences of Pediatric Obesity: A Review of Pathophysiology, Screening, and Treatment.
Gunaratne N; Deplewski D
Pediatr Ann; 2023 Feb; 52(2):e62-e67. PubMed ID: 36779885
[TBL] [Abstract][Full Text] [Related]
2. Identification and treatment of metabolic complications in pediatric obesity.
Ode KL; Frohnert BI; Nathan BM
Rev Endocr Metab Disord; 2009 Sep; 10(3):167-88. PubMed ID: 19809879
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of comorbid conditions pre-existing and diagnosed at a tertiary care pediatric weight management clinic.
Leon G; de Klerk E; Ho J; Jackman M; Reimer RA; Connors KE; Luca P
J Pediatr Endocrinol Metab; 2018 Mar; 31(4):385-390. PubMed ID: 29432207
[TBL] [Abstract][Full Text] [Related]
4. Metabolic consequences of obesity and insulin resistance in polycystic ovary syndrome: diagnostic and methodological challenges.
Jeanes YM; Reeves S
Nutr Res Rev; 2017 Jun; 30(1):97-105. PubMed ID: 28222828
[TBL] [Abstract][Full Text] [Related]
5. Screening for metabolic and reproductive complications in obese children and adolescents.
Irizarry KA; Brito V; Freemark M
Pediatr Ann; 2014 Sep; 43(9):e210-7. PubMed ID: 25198445
[TBL] [Abstract][Full Text] [Related]
6. Pediatric Type 2 Diabetes: Not a Mini Version of Adult Type 2 Diabetes.
Savic Hitt TA; Katz LEL
Endocrinol Metab Clin North Am; 2020 Dec; 49(4):679-693. PubMed ID: 33153674
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of Prediabetes and Type 2 Diabetes in Children With Nonalcoholic Fatty Liver Disease.
Newton KP; Hou J; Crimmins NA; Lavine JE; Barlow SE; Xanthakos SA; Africa J; Behling C; Donithan M; Clark JM; Schwimmer JB;
JAMA Pediatr; 2016 Oct; 170(10):e161971. PubMed ID: 27478956
[TBL] [Abstract][Full Text] [Related]
8. Insulin resistance and insulin hypersecretion in the metabolic syndrome and type 2 diabetes: Time for a conceptual framework shift.
Nolan CJ; Prentki M
Diab Vasc Dis Res; 2019 Mar; 16(2):118-127. PubMed ID: 30770030
[TBL] [Abstract][Full Text] [Related]
9. Nonalcoholic fatty liver disease and polycystic ovary syndrome.
Vassilatou E
World J Gastroenterol; 2014 Jul; 20(26):8351-63. PubMed ID: 25024594
[TBL] [Abstract][Full Text] [Related]
10. [Obesity--significance in adolescence and for reproduction].
Wolf AS; Sterzik K
Zentralbl Gynakol; 1998; 120(5):210-22. PubMed ID: 9629628
[TBL] [Abstract][Full Text] [Related]
11. Systematic review: association of polycystic ovary syndrome with metabolic syndrome and non-alcoholic fatty liver disease.
Baranova A; Tran TP; Birerdinc A; Younossi ZM
Aliment Pharmacol Ther; 2011 Apr; 33(7):801-14. PubMed ID: 21251033
[TBL] [Abstract][Full Text] [Related]
12. Children's Hospital Association consensus statements for comorbidities of childhood obesity.
Estrada E; Eneli I; Hampl S; Mietus-Snyder M; Mirza N; Rhodes E; Sweeney B; Tinajero-Deck L; Woolford SJ; Pont SJ;
Child Obes; 2014 Aug; 10(4):304-17. PubMed ID: 25019404
[TBL] [Abstract][Full Text] [Related]
13. [Not Available].
Beck-Nielsen H
Ugeskr Laeger; 2022 Oct; 184(42):. PubMed ID: 36305255
[TBL] [Abstract][Full Text] [Related]
14. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 2.
Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
Endocr Pract; 2015 Dec; 21(12):1415-26. PubMed ID: 26642102
[TBL] [Abstract][Full Text] [Related]
15. Cardiometabolic risk in obese children.
Chung ST; Onuzuruike AU; Magge SN
Ann N Y Acad Sci; 2018 Jan; 1411(1):166-183. PubMed ID: 29377201
[TBL] [Abstract][Full Text] [Related]
16. The relationship between pancreas steatosis and the risk of metabolic syndrome and insulin resistance in Chinese adolescents with concurrent obesity and non-alcoholic fatty liver disease.
Chiyanika C; Chan DFY; Hui SCN; So HK; Deng M; Yeung DKW; Nelson EAS; Chu WCW
Pediatr Obes; 2020 Sep; 15(9):e12653. PubMed ID: 32351030
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular and Metabolic Complications - Diagnosis and Management in Obese Children.
Vikram NK
Indian J Pediatr; 2018 Jul; 85(7):535-545. PubMed ID: 29218646
[TBL] [Abstract][Full Text] [Related]
18. Associations of vitamin D with insulin resistance, obesity, type 2 diabetes, and metabolic syndrome.
Wimalawansa SJ
J Steroid Biochem Mol Biol; 2018 Jan; 175():177-189. PubMed ID: 27662816
[TBL] [Abstract][Full Text] [Related]
19. Glucagon-Like Peptide-1 Receptor Agonists and Dual Glucose-Dependent Insulinotropic Polypeptide/Glucagon-Like Peptide-1 Receptor Agonists in the Treatment of Obesity/Metabolic Syndrome, Prediabetes/Diabetes and Non-Alcoholic Fatty Liver Disease-Current Evidence.
Muzurović EM; Volčanšek Š; Tomšić KZ; Janež A; Mikhailidis DP; Rizzo M; Mantzoros CS
J Cardiovasc Pharmacol Ther; 2022; 27():10742484221146371. PubMed ID: 36546652
[TBL] [Abstract][Full Text] [Related]
20. Review of nonalcoholic fatty liver disease in women with polycystic ovary syndrome.
Kelley CE; Brown AJ; Diehl AM; Setji TL
World J Gastroenterol; 2014 Oct; 20(39):14172-84. PubMed ID: 25339805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
